American Vanguard (NYSE:AVD – Get Free Report) is projected to issue its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $163.00 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Monday, March 16, 2026 at 10:30 AM ET.
American Vanguard Trading Up 0.4%
AVD opened at $4.49 on Tuesday. The firm has a market cap of $127.83 million, a price-to-earnings ratio of -1.13 and a beta of 1.23. American Vanguard has a 52 week low of $3.28 and a 52 week high of $5.92. The business’s 50 day moving average is $4.65 and its two-hundred day moving average is $4.84. The company has a quick ratio of 0.90, a current ratio of 1.77 and a debt-to-equity ratio of 0.82.
Institutional Trading of American Vanguard
Institutional investors have recently bought and sold shares of the company. Strs Ohio acquired a new position in American Vanguard during the first quarter worth about $28,000. nVerses Capital LLC purchased a new position in shares of American Vanguard during the 4th quarter worth $42,000. Virtu Financial LLC acquired a new stake in shares of American Vanguard during the fourth quarter worth $52,000. Jain Global LLC purchased a new position in shares of American Vanguard during the 4th quarter worth about $53,000. Finally, XTX Topco Ltd acquired a new stake in shares of American Vanguard during the 2nd quarter worth $57,000. 79.00% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Read Our Latest Stock Report on American Vanguard
American Vanguard Company Profile
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Recommended Stories
- Five stocks we like better than American Vanguard
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- My Epstein Story
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
